Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Idexx Laboratories (IDXX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,595,574
  • Shares Outstanding, K 86,007
  • Annual Sales, $ 2,213 M
  • Annual Income, $ 377,030 K
  • 60-Month Beta 0.97
  • Price/Sales 8.19
  • Price/Cash Flow 39.51
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 1.04
  • Number of Estimates 4
  • High Estimate 1.08
  • Low Estimate 0.97
  • Prior Year 1.01
  • Growth Rate Est. (year over year) +2.97%

Price Performance

See More
Period Period Low Period High Performance
1-Month
198.74 +8.55%
on 03/08/19
217.97 -1.02%
on 03/18/19
+5.48 (+2.61%)
since 02/15/19
3-Month
176.11 +22.50%
on 01/03/19
217.97 -1.02%
on 03/18/19
+28.17 (+15.02%)
since 12/18/18
52-Week
176.11 +22.50%
on 01/03/19
256.22 -15.80%
on 08/29/18
+11.01 (+5.38%)
since 03/16/18

Most Recent Stories

More News
Allscripts Partners With Opargo to Boost Practice Management

Allscripts' (MDRX) partnership with Opargo is likely to improve scheduling capabilities and practice workflows of Allscripts Practice Management solution.

WMGI : 32.16 (-0.53%)
ABMD : 333.25 (+0.01%)
MDRX : 10.45 (-1.69%)
IDXX : 215.74 (-0.22%)
Stryker Buys Israel-Based OrthoSpace, Strengthens MedSurg

Strong international presence and an acquisition-driven strategy are likely to fortify Stryker's (SYK) footprint in the global MedTech space.

WMGI : 32.16 (-0.53%)
SYK : 193.58 (-0.24%)
ABMD : 333.25 (+0.01%)
IDXX : 215.74 (-0.22%)
Look for Shares of Idexx Labs to Potentially Pullback after Yesterday's 1.65% Rise

Idexx Labs (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $211.80 to a high of $214.34. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $211.07...

IDXX : 215.74 (-0.22%)
Allscripts Strengthens Strategic Relationship with Pulse8

Pulse8 is likely to boost Allscripts' (MDRX) flagship platform Veradigm, and its existing health plan product suite that delivers pocket-friendly tools and services for health plan members.

WMGI : 32.16 (-0.53%)
ABMD : 333.25 (+0.01%)
MDRX : 10.45 (-1.69%)
IDXX : 215.74 (-0.22%)
Here's Why Investors Should Retain McKesson (MCK) Stock Now

McKesson (MCK) is well positioned for growth backed by strong business plans and robust surprise trend amid cutthroat competition in the near term.

WMGI : 32.16 (-0.53%)
MCK : 121.37 (+1.77%)
ABMD : 333.25 (+0.01%)
IDXX : 215.74 (-0.22%)
Allscripts to Fortify Middle East Foothold With New Project

Qatar-based Alfardan Group and Chicago-based Northwestern Medicine select Allscripts (MDRX) for the launch of a project in the Middle East.

WMGI : 32.16 (-0.53%)
ABMD : 333.25 (+0.01%)
MDRX : 10.45 (-1.69%)
IDXX : 215.74 (-0.22%)
Here's Why Investors Should Bet on Cooper Companies (COO) Now

Cooper Companies (COO) maintains its leading position in the markets of specialty lenses. Further, the company exits first-quarter fiscal 2019 on a strong note.

WMGI : 32.16 (-0.53%)
COO : 293.18 (-0.69%)
ABMD : 333.25 (+0.01%)
IDXX : 215.74 (-0.22%)
After Yesterday's Decline of 1.91%, Idexx Labs Offers Investors Better Value

Idexx Labs (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $199.67 to a high of $203.89. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $203.56...

IDXX : 215.74 (-0.22%)
Here's Why Investors Should Bet on Merit Medical (MMSI) Now

Merit Medical's (MMSI) upbeat guidance for 2019 is indicative of the company's brighter prospects.

WMGI : 32.16 (-0.53%)
MMSI : 60.19 (-1.15%)
ABMD : 333.25 (+0.01%)
IDXX : 215.74 (-0.22%)
Baxter (BAX) Gets FDA Approval for Eptifibatide to Treat ACS

Baxter's (BAX) Eptifibatide is a platelet aggregation inhibitor that prevents platelets-specialized blood cells clotting.

WMGI : 32.16 (-0.53%)
ABMD : 333.25 (+0.01%)
IDXX : 215.74 (-0.22%)
BAX : 76.95 (+0.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade IDXX with:

Business Summary

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff...

See More

Key Turning Points

2nd Resistance Point 220.31
1st Resistance Point 218.03
Last Price 215.74
1st Support Level 213.40
2nd Support Level 211.05

See More

52-Week High 256.22
Fibonacci 61.8% 225.62
Fibonacci 50% 216.17
Last Price 215.74
Fibonacci 38.2% 206.71
52-Week Low 176.11

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar